Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M103Revenue (TTM) $M43.8Net Margin (%)-93.6Altman Z-Score-6.4
Enterprise Value $M87.3EPS (TTM) $-0.8Operating Margin %-86.2Piotroski F-Score5
P/E(ttm)--Beneish M-Score-3.5Pre-tax Margin (%)-93.6Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio1.6Cash flow > EarningsY
Price/Sales2.35-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-50.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-281.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M54.1ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with BDSI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BDSIJulian Robertson 2015-06-30 Sold Out -0.9%$7.26 - $10.5
($8.62)
$ 1.90-78%Sold Out0
BDSIJulian Robertson 2013-12-31 Buy 0.92%$4.24 - $5.98
($5.13)
$ 1.90-63%New holding510,874
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BDSI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BDSI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SEARS SAMUEL P JRDirector 2016-12-01Sell12,000$1.6713.77view
Feinberg Barry IDirector 2016-11-23Buy2,000$1.6713.77view
Feinberg Barry IDirector 2016-11-17Buy3,000$1.871.6view
ODONNELL FRANCIS E JRDirector 2016-09-23Sell100,000$2.57-26.07view
Vasisht NirajChief Technology Officer 2016-09-23Sell47,000$2.43-21.81view
De Paolantonio Ernest RobertCFO, Secretary and Treasurer 2016-09-22Sell14,800$2.44-22.13view
Feinberg Barry IDirector 2016-08-25Buy2,500$2.55-25.49view
STONE WILLIAM BDirector 2016-08-11Sell16,000$2.57-26.07view
Bramlage CharlesDirector 2016-03-21Buy8,850$2.82-32.62view
Vasisht NirajChief Technology Officer 2016-03-18Buy1,000$2.8-32.14view

Quarterly/Annual Reports about BDSI:

News about BDSI:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BioDelivery Sciences International, TheStreet, Antares Pharma Mar 27 2016 
Weekly CEO Sells Highlight: Vringo Inc, Medivation Inc, BioDelivery Sciences International Inc and H Feb 02 2014 
Weekly CFO Sells Highlight: BDSI, LNKD, VRSK, ABMD, AGX Jul 17 2012 
BioDelivery Sciences International Inc. Reports Operating Results (10-K/A) Nov 19 2010 
BioDelivery Sciences International Inc. Reports Operating Results (10-Q) Aug 09 2010 
BioDelivery Sciences International Inc. Reports Operating Results (10-Q) Aug 09 2010 
BioDelivery Sciences International Inc. (BDSI) CEO Mark A Sirgo buys 4,022 Shares Jun 10 2010 
BioDelivery Sciences International Inc. (BDSI) CEO Mark A Sirgo buys 4,450 Shares May 24 2010 
BioDelivery Sciences International Inc. Reports Operating Results (10-Q) May 10 2010 
Weekly CEO Buys Highlight: Saul Centers Inc, Trans World Entertainment Corp, NorthWestern Corp, Nort Apr 05 2010 

More From Other Websites
Is BioDelivery Sciences (BDSI) a Great Growth Stock? Jan 17 2017
MonoSol Rx Files Patent Infringement Suit against BioDelivery Sciences International (BDSI) Jan 13 2017
BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Other Events, Financial Statements and... Jan 09 2017
BioDelivery Sciences Closes Transaction to Reacquire License to BELBUCA® from Endo Pharmaceuticals Jan 09 2017
Is the Options Market Predicting a Spike in BioDelivery (BDSI) Stock? Jan 04 2017
Endo International Is Top 'Dog of the S&P 500' Dec 30 2016
BioDelivery Sciences Announces the Hiring of Peter Ginsberg as Vice President of Business... Dec 14 2016
BIODELIVERY SCIENCES INTERNATIONAL INC Files SEC form 8-K, Entry into a Material Definitive... Dec 13 2016
BioDelivery Sciences Announces Clonidine Topical Gel for Painful Diabetic Neuropathy Phase 2b Trial... Dec 13 2016
BioDelivery Sciences International, Inc. (BDSI): How It Stacks Up Against Its Peers Dec 12 2016
Endo (ENDP) Inks Deal to Return Belbuca Rights to BioDelivery Dec 09 2016
After Endo, global plans for BDSI’s Belbuca? Dec 09 2016
BioDelivery Reacquires Rights for Opioid Painkiller Dec 08 2016
ETFs with exposure to BioDelivery Sciences International, Inc. : December 8, 2016 Dec 08 2016
Endo Sells Back Its Rights to Opioid Drug and Moves to Restructure Dec 08 2016
[$$] Endo Sells Back Rights for Opioid Painkiller Dec 08 2016
BioDelivery Sciences Reacquires License to BELBUCA™ from Endo Pharmaceuticals Dec 08 2016
BioDelivery Sciences: Can Bunvail and Belbuca's Sales Improve? Nov 28 2016
BioDelivery Sciences to Present at the 28th Annual Piper Jaffray Healthcare Conference Nov 23 2016
BIODELIVERY SCIENCES INTERNATIONAL INC Financials Nov 17 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)